Kei Furukawa

Mitsui & Co. Global Investment Ltd is a private Equity/venture Capital firm, a subsidiary of Mitsui & Co., Ltd. founded in 1996. The firm is headquartered in Tokyo.

Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California.

FILWEL Co., Ltd. engages in the manufacture and sale of precision polishing pads and artificial leather materials. Its porducts include non-woven and suede Bellatrix polishing pads, Bellace artificial leather, Belluria, and Air Cool. The company was founded on November 17, 2004 and is headquartered in Hofu, Japan.

AccuRna, Inc. researches and develops nucleic acid-based drugs using drug delivery system technologies. The company was founded on December 18, 2015 and is headquartered in Tokyo, Japan.

Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA.

Braizon Therapeutics, Inc. is a Japanese company that engages in researching and developing drugs. The company was founded in 2015 by Mariko Tosu. The CEO is Bunichi Wanibuchi.

Rin Institute, Inc. is a company based in Tokyo, Japan that was founded in 2016 by Kentaro Yoshimatsu. The Japanese company's website simply states that it is "just another WordPress site."

Adriakaim, Inc. manufactures and sells medical and health-related equipment. The company is based in Tokyo, Japan. Additionally, the Japanese company provides management and technology strategy consulting services. The company was founded in 2018 by Masatoshi Kobayashi, Hiroyuki Imabayashi.

Fimecs, Inc. is a technology company based in Fujisawa, Japan. Fimecs was ranked second in the world by KPMG Private Enterprise's Tech Innovator 2022. The Japanese company was founded in 2018 by Yusuke Tominari and Kanae Kaba, with Yusuke Tominari serving as the CEO since then.

Theoria Science KK is a company founded in 2012 and based in Tokyo, Japan. The Japanese company specializes in exosome research and offers the latest clinical knowledge and expertise in the field. Theoria Science is focused on developing early detection methods and therapeutic drugs for various diseases, including blood cancer. The company also provides medical services related to exosome research, such as early risk detection tests.